In this context, blockade of the Spingosine 1 phosphate receptor 1/STAT3 loop using the S1PR1 antagonist FTY720 led to decreased tumorigenesis in group 3 medulloblastoma patient-derived xenografts29. Here, STAT3 is linked to medulloblastoma.